Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129045) titled 'Signal-receiver Co-Enhancement Strategy: Neuron-Targeted and Conductive Hydrogel Promotes Sensory Nerve Recovery through NGF-TRKA Activation for Diabetic Bone Regeneration' on July 29.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: The Third Affiliated Hospital of AFMU
Condition:
Diabetes mellitus
Intervention:
Group of patients with diabetes:None
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2026-08-01
Target Sample Size: Group of patients with diabetes:8;Non-diabetic control group:8;
Countries of Recruitment:
China
To know more, visit https...